Literature DB >> 3495366

Increased accumulation of chloroquine and desethylchloroquine in homozygous sickle cells.

A U Orjih.   

Abstract

The effect of haemoglobin genotype on the level of chloroquine in the erythrocytes of homozygous sickle-cell (SS), normal (AA), and heterozygous (AS) subjects was investigated in vivo and in vitro. Two hours after a single oral dose of chloroquine its level in plasma was consistently lower in SS than in AA subjects. In contrast, its level in the erythrocytes was higher in SS than in AA subjects. Desethylchloroquine, a metabolite of chloroquine, was detected only in the erythrocytes of SS blood but was present in both the plasma and erythrocytes of AA blood. For the in vitro test, a 5% suspension of erythrocytes was incubated for 1 hour with a 2.06 mumol/l solution of chloroquine. The mean chloroquine distribution ratio (mumol chloroquine per kg erythrocytes:mumol chloroquine per litre medium) was 31.0, 3.5, and 2.7 for SS, AA, and AS erythrocytes, respectively. The results of the study indicate that haemoglobin genotype appears to influence the level of chloroquine in erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495366      PMCID: PMC2490867     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  14 in total

1.  In-vivo and in-vitro assessment of chloroquine-resistant Plasmodium falciparum malaria in Zanzibar.

Authors:  I K Schwartz; D Payne; C C Campbell; O J Khatib
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

2.  Possible role of drug malabsorption in recrudescence of falciparum malaria.

Authors:  C Herzog; C J Ellis; J A Innes; K A Fletcher
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

3.  High-level chloroquine resistance of Plasmodium falciparum malaria acquired in Kenya.

Authors:  B G Weniger; R S Blumberg; C C Campbell; T C Jones; D L Mount; S M Friedman
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

4.  Membrane-bound hemichrome in density-separated cohorts of normal (AA) and sickled (SS) cells.

Authors:  H Q Campwala; J F Desforges
Journal:  J Lab Clin Med       Date:  1982-01

5.  Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites.

Authors:  A C Chou; R Chevli; C D Fitch
Journal:  Biochemistry       Date:  1980-04-15       Impact factor: 3.162

6.  Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.

Authors:  Y Bergqvist; B Domeij-Nyberg
Journal:  J Chromatogr       Date:  1983-01-14

7.  Chloroquine resistance in malaria: a deficiency of chloroquine binding.

Authors:  C D Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

8.  Denatured hemoglobin in sickle erythrocytes.

Authors:  T Asakura; K Minakata; K Adachi; M O Russell; E Schwartz
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

9.  Kinetics of the uptake and elimination of chloroquine in children with malaria.

Authors:  S A Adelusi; A H Dawodu; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

10.  Serum concentrations of chloroquine in a patient with a late recrudescence of Kenyan Plasmodium falciparum malaria.

Authors:  M Faehlmann; L Rombo; P Hedman
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

View more
  5 in total

1.  Chloroquine-induced pruritus and sickle cell gene trait in Africans: possible pharmacogenetic relationship.

Authors:  J O Ogunranti; J C Aguiyi; S Roma; K E Onwukeme
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Authors:  Elizabeth A Ashley; Kasia Stepniewska; Niklas Lindegardh; Anna Annerberg; Joel Tarning; Rose McGready; Lucy Phaiphun; Pratap Singhasivanon; Nicholas J White; François Nosten
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

3.  A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.

Authors:  George O Adjei; Bamenla Q Goka; Christabel C Enweronu-Laryea; Onike P Rodrigues; Lorna Renner; Abdul M Sulley; Michael Alifrangis; Insaf Khalil; Jorgen A Kurtzhals
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

4.  Population Pharmacokinetic Estimates Suggest Elevated Clearance and Distribution Volume of Desethylamodiaquine in Pediatric Patients with Sickle Cell Disease Treated with Artesunate-Amodiaquine.

Authors:  George O Adjei; Seth K Amponsah; Bamenla Q Goka; Christabel Enweronu-Laryea; Lorna Renner; Abdul Malik Sulley; Michael Alifrangis; Jorgen A L Kurtzhals
Journal:  Curr Ther Res Clin Exp       Date:  2019-01-12

5.  Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?

Authors:  Eric A Gbessi; Offianan A Toure; Albert Gnondjui; Tossea S Koui; Baba Coulibaly; Berenger A Ako; Nguessan L Tiacoh; Serge-Brice Assi; Ibrahima Sanogo; Didier-Paulin Sokouri; Ronan Jambou
Journal:  Parasite       Date:  2021-09-27       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.